These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vibrational analysis of amino acids and short peptides in aqueous media. V. The effect of the disulfide bridge on the structural features of the peptide hormone somatostatin-14. Hernández B; Carelli C; Coïc YM; De Coninck J; Ghomi M J Phys Chem B; 2009 Sep; 113(38):12796-803. PubMed ID: 19708669 [TBL] [Abstract][Full Text] [Related]
8. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution. Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647 [TBL] [Abstract][Full Text] [Related]
9. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B. Thibault G; Grove KL; Deschepper CF Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004 [TBL] [Abstract][Full Text] [Related]
10. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8. Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213 [TBL] [Abstract][Full Text] [Related]
11. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2. Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702 [TBL] [Abstract][Full Text] [Related]
13. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies. Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues. Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556 [TBL] [Abstract][Full Text] [Related]
15. Structural determinants of natriuretic peptide receptor specificity and degeneracy. He XL; Dukkipati A; Garcia KC J Mol Biol; 2006 Aug; 361(4):698-714. PubMed ID: 16870210 [TBL] [Abstract][Full Text] [Related]
16. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Imura H; Nakao K; Itoh H Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000 [TBL] [Abstract][Full Text] [Related]
17. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. Raynor K; Reisine T J Pharmacol Exp Ther; 1989 Nov; 251(2):510-7. PubMed ID: 2572690 [TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20. Demchyshyn LL; Srikant CB; Sunahara RK; Kent G; Seeman P; Van Tol HH; Panetta R; Patel YC; Niznik HB Mol Pharmacol; 1993 Jun; 43(6):894-901. PubMed ID: 8100352 [TBL] [Abstract][Full Text] [Related]
19. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype. Mimeault M; Fournier A; Féthiere J; De Léan A Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides. Tamura N; Ogawa Y; Itoh H; Arai H; Suga S; Nakagawa O; Komatsu Y; Kishimoto I; Takaya K; Yoshimasa T J Clin Invest; 1994 Sep; 94(3):1059-68. PubMed ID: 8083346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]